科研不端行为:有多严重?可以做些什么?

Future Prescriber Pub Date : 2012-07-11 DOI:10.1002/fps.88

Steve Chaplin MSc, MRPharmS

{"title":"科研不端行为:有多严重?可以做些什么?","authors":"Steve Chaplin MSc, MRPharmS","doi":"10.1002/fps.88","DOIUrl":null,"url":null,"abstract":"<p>We make two important assumptions when appraising the evidence behind an intervention: that the data are genuine and that they represent the total body of relevant knowledge. Doubts have been growing about both. Research misconduct and selective reporting of clinical trials are undermining confidence in scientific data, and the response of the research establishment has been mixed. Copyright © 2012 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"13 1","pages":"5-76"},"PeriodicalIF":0.0000,"publicationDate":"2012-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.88","citationCount":"2","resultStr":"{\"title\":\"Research misconduct: how bad is it and what can be done?\",\"authors\":\"Steve Chaplin MSc, MRPharmS\",\"doi\":\"10.1002/fps.88\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We make two important assumptions when appraising the evidence behind an intervention: that the data are genuine and that they represent the total body of relevant knowledge. Doubts have been growing about both. Research misconduct and selective reporting of clinical trials are undermining confidence in scientific data, and the response of the research establishment has been mixed. Copyright © 2012 John Wiley & Sons, Ltd.</p>\",\"PeriodicalId\":100566,\"journal\":{\"name\":\"Future Prescriber\",\"volume\":\"13 1\",\"pages\":\"5-76\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/fps.88\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Prescriber\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/fps.88\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.88","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Research misconduct: how bad is it and what can be done?

We make two important assumptions when appraising the evidence behind an intervention: that the data are genuine and that they represent the total body of relevant knowledge. Doubts have been growing about both. Research misconduct and selective reporting of clinical trials are undermining confidence in scientific data, and the response of the research establishment has been mixed. Copyright © 2012 John Wiley & Sons, Ltd.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Future Prescriber

自引率

0.00%

发文量